MktsMarkets

Revelation Biosciences, Inc.
NASDAQ: REVBKey statistics
REVB News
Stories mentioning REVB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,377 | 964.00 | 923.00 | 1,318 | 859.00 | 605.00 | 831.00 | 1,395 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 3,093 | 2,572 | 1,943 | 2,461 | 2,095 | 1,754 | 1,797 | 2,522 |
| Operating Income (Loss) | (3,092) | (2,572) | (1,943) | (2,461) | (2,095) | (1,754) | (1,797) | (2,522) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 83.00 | 61.00 | 35.00 | 17.00 | 42.00 | 26.00 | (451.00) | (5,872) |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income (Loss) | (3,009) | (2,512) | (1,907) | (2,444) | (2,051) | (1,726) | (2,242) | (8,390) |
| Earnings Per Share (Basic) | (2.71) | (4.05) | (1.77) | (7.01) | (25.34) | (123.29) | (40.15) | (246.27) |
| Earnings Per Share (Diluted) | (2.71) | (4.05) | (1.77) | (7.01) | (25.34) | (123.29) | (40.15) | (246.27) |
| Weighted Average Shares Outstanding (Basic) | 3,208 | 621.00 | 2,645 | 803.00 | 81.00 | 14.00 | 56.00 | 34.00 |
| Weighted Average Shares Outstanding (Diluted) | 3,208 | 621.00 | 2,645 | 803.00 | 81.00 | 14.00 | 56.00 | 34.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About REVB
Revelation Biosciences, Inc. (NASDAQ: REVB) is a stock listed on the Nasdaq Stock Market under the ticker symbol REVB. It last traded at $0.4800 (Oct 16, 2026, 4:00 PM ET), down 36.4% on the day. That gives Revelation Biosciences a market capitalisation of $1.9M.
Over the past 52 weeks REVB has traded between $0.4700 and $5.80.
For the quarter ended Mar 31, 2026 it reported a net loss of $3.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$3.0M |
| Dec 31, 2025 | — | -$2.5M |
| Sep 30, 2025 | — | -$1.9M |
| Jun 30, 2025 | — | -$2.4M |
From Revelation Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…